Clinical Trial

Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial

Study acronym: PARMA
Suspended Phase 2
View on ClinicalTrials.gov →
Why the trial stopped
Suspended for review and amendments to study documents.
Summary
Acute respiratory distress syndrome (ARDS) is a serious and potentially life-threatening lung condition that can affect children. Currently, ventilator settings commonly used in treatment are based on approaches developed for adults, and it remains unclear whether these settings are equally effective for children. Because children's bodies respond differently than adults', it is important to determine the most effective ventilator strategies specifically for pediatric patients. This study will compare two different ventilator approaches in children with ARDS to identify which method provides the greatest benefit. The findings will also help inform the design of a larger study in the future.
Protocol Amendment History 2 changes
critical Recruitment suspended 2026-08-15
critical Recruitment suspended: Suspended for review and amendments to study documents. 2026-08-15
Trial Details
NCT Number NCT07123961
Lead Sponsor Children's Hospital of Philadelphia
Collaborators: University of Pennsylvania
Conditions Acute Respiratory Distress Syndrome (ARDS), Ventilator Management, Lung-protective Ventilation, Pediatric Acute Respiratory Distress Syndrome (PARDS)
Enrollment 160 participants
Start Date 2025-11-07
Primary Completion 2029-12-31 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14